Trial Profile
A multicenter, randomized, double-blind, placebo-controlled study of the effect of ezetimibe plus simvastatin compared with simvastatin alone on flow-mediated brachial artery vasoactivity in subjects with primary hypercholesterolemia (The EFFECTS trial)
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 09 May 2022
Price :
$35
*
At a glance
- Drugs Ezetimibe (Primary) ; Simvastatin (Primary)
- Indications Hypercholesterolaemia
- Focus Pharmacodynamics
- Acronyms EFFECTS
- Sponsors Organon
- 23 Apr 2008 New trial record.